Anatool Tool Has Improved Anaphylaxis Clinical Support
Clinicians can use this new digital tool to help identify anaphylaxis and manage weight-based epinephrine dosing.
Updated on Oct. 6, 2026 in Allergies
Live Poll
Do you trust clinical software tools to assist doctors in making high-stakes medical treatment decisions?
Food Allergy Research & Education has launched Anatool, an online clinical support system designed to guide healthcare providers through the identification and treatment of anaphylaxis. The tool aims to improve emergency response by offering standardized, evidence-based protocols.
Why it matters
Epinephrine is often underused in community settings, and paper-based clinical pathways can be prone to oversimplification or neglect. Anatool addresses these gaps by digitizing the latest consensus criteria to ensure clinicians have precise, actionable dosing support.
Anatool integrates guidelines from the 2024 international anaphylaxis consensus report to assist clinicians with diagnosis and weight-based epinephrine dosing. Its clinical efficacy depends on user input accuracy, which remains under investigation in broader clinical settings.
The players
Food Allergy Research & Education
A national advocacy organization dedicated to the research, education, and support of individuals living with food allergies.
Altrix Medical
A technology firm that assisted in the development of clinical digital support tools for medical professionals.
Cincinnati Children's Hospital Medical Center
A pediatric academic medical center that serves as a hub for clinical research and child health innovation.
The details
The tool functions by prompting clinicians to select the type of allergen exposure, which then triggers embedded algorithms to evaluate symptom responses and identify potential anaphylaxis. It provides step-by-step instructions for epinephrine administration and includes a built-in timer to manage symptom reassessment. By restricting access to verified healthcare professionals, the developers ensure that the clinical recommendations are applied within an appropriate medical context.
Timeline
2006: NIAID/FAAN anaphylaxis criteria were published.
2024: International anaphylaxis consensus recommendations were published.
October 6, 2026: The article detailing the Anatool release was published.
Health Landscape
Anatool represents a move toward digital-first decision support in emergency medicine to modernize the clinical response to severe allergies. It builds upon the 2024 international anaphylaxis consensus recommendations to standardize care across clinical settings.
While this tool is restricted to healthcare professionals, it highlights the importance of recognizing that epinephrine is often underused during anaphylactic events. Patients with known allergies should discuss their emergency action plans and the proper timing of epinephrine use with their physician.
The takeaway
Anatool standardizes anaphylaxis treatment by providing clinicians with real-time, weight-based dosing support during emergencies. If you or a family member have a severe food allergy, talk to your doctor to ensure your written anaphylaxis emergency plan is up to date and readily accessible.
What happens next
Developers plan to launch a smartphone app designed for patients and caregivers in the future.
Further reading
For more information on managing severe immune responses, visit our guide on Allergies.
Source note: This article includes information reported by Healio.
Live Poll
Do you trust clinical software tools to assist doctors in making high-stakes medical treatment decisions?
